E2FBP1/hDril1 modulates cell growth through downregulation of promyelocytic leukemia bodies

Cell Death and Differentiation

Volumn 11, Issue 7, 2004, Pages 747-759

  Fukuyo, Y ^a,b   Mogi, K ^a   Tsunematsu, Y ^b   Nakajima, T ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

PML nuclear body; Premature senescence; Protein protein interaction; Sumoylation

Indexed keywords

ADENINE; DNA BINDING PROTEIN; DRIL1 PROTEIN; THYMINE; TRANSCRIPTION FACTOR E2F BINDING PROTEIN 1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; AT RICH SEQUENCE; CELL AGING; CELL DEATH; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOSIS INHIBITION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; RNA INTERFERENCE;

BLOTTING, WESTERN; CELL DIVISION; CELL NUCLEUS STRUCTURES; DNA-BINDING PROTEINS; DOWN-REGULATION; ESCHERICHIA COLI; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUORESCENT DYES; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; KB CELLS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICROSCOPY, FLUORESCENCE; NUCLEAR PROTEINS; ONCOGENES; PRECIPITIN TESTS; RNA, SMALL INTERFERING; SACCHAROMYCES CEREVISIAE; TRANS-ACTIVATORS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 3543097985     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401412     Document Type: Article

References (36)

1. Suzuki M, Okuyama S, Okamoto S, Shirasuna K, Nakajima T, Hachiya T, Nojima H, Sekiya S and Oda K (1998) A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer. Oncogene 17: 853-865
2. Kortschak RD, Reimann H, Zimmer M, Eyre HJ, Saint R and Jenne DE (1998) The human dead ringer/bright homolog, DRIL1: cDNA cloning, gene structure, and mapping to D19S886, a marker on 19p13.3 that is strictly linked to the Peutz-Jeghers syndrome. Genomics 51: 288-292
3. Kortschak RD, Tucker PW and Saint R (2000) ARID proteins come in from the desert. Trends Biochem. Sci. 25: 294-299
4. Gong L, Kamitani T, Fujise K, Caskey LS and Yeh ET (1997) Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J. Biol. Chem. 272: 28198-28201
5. Zong RT, Das C and Tucker PW (2000) Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies. EMBO J. 19: 4123-4133
6. Webb CF (2001) The transcription factor, Bright, and immunoglobulin heavy chain expression. Immunol. Res. 24: 149-161
7. Herrscher RF, Kaplan MH, Lelsz DL, Das C, Scheuermann R and Tucker PW (1995) The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev. 9: 3067-3082
8. Borden KL (2002) Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol. Cell Biol. 22: 5259-5269
9. Maul GG, Negorev D, Bell P and Ishov AM (2000) Review: properties and assembly mechanisms of ND10, PMIL bodies, or PODs. J. Struct. Biol. 129: 278-287
10. Negorev D and Maul GG (2001) Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 20: 7234-7242
11. Seeler JS and Dejean A (1999) The PML nuclear bodies: actors or extras? Curr. Opin. Genet. Dev. 9: 362-367
12. Eskiw CH and Bazett-Jones DP (2002) The promyelocytic leukemia nuclear body: sites of activity? Biochem. Cell Biol. 80: 301-310
13. Pearson M and Pelicci PG (2001) PML interaction with p53 and its role in apoptosis and replicative senescence. Oncogene 20: 7250-7256
14. Salomoni P and Pandolfi PP (2002) The role of PML in tumor suppression. Cell 108: 165-170
15. Everett RD (2001) DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20: 7266-7273
16. Benoit G, Roussel M, Pendino F, Segal-Bendirdjian E and Lanotte M (2001) Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation. Oncogene 20: 7161-7177
17. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP and Pelicci PG (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406: 207-210
18. Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C and Lowe SW (2000) PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14: 2015-2027
19. James P, Halladay J and Craig EA (1996) Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144: 1425-1436
20. Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K, Pandolfi PP, Will H, Schneider C and Del Sal G (2000) Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19: 6185-6195
21. Everett RD, Lomonte P, Sternsdorf T, van Driel R and Orr A (1999) Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112 (Part 24): 4581-4588
22. Zhong S, Müller S, Ronchetti S, Freemont PS, Dejean A and Pandolfi PP (2000) Role of SUMO-1-modified PML in nuclear body formation. Blood 95: 2748-2752
23. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, Yeh ET, Strauss 3rd JF and Maul GG (1999) PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147: 221-234
24. Best JL, Ganiatsas S, Agarwal S, Changou A, Salomoni P, Shirihai O, Meluh PB, Pandolfi PP and Zon LI (2002) SUMO-1 protease-1 regulates gene transcription through PML. Mol. Cell 10: 843-855
25. Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, Scheffner M and Del Sal G (1999) Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18: 6462-6471
26. Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP and Hay RT (1999) SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18: 6455-6461
27. Li S-J and Hochstrasser M (1999) A new protease required for cell-cycle progression in yeast. Nature 398: 246-251
28. Hannon GJ (2002) RNA interference. Nature 418: 244-251
29. Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G and Hara E (2001) Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409: 1067-1070
30. Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602
31. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelji I, Pereira-Smith O, Peacocke M and Campisi J (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92: 9363-9367
32. Xu ZX, Timanova-Atanasova A, Zhao RX and Chang KS (2003) PML colocalizes with and stabilizes the DNA damage response protein TopBP1. Mol. Cell Biol. 23: 4247-4256
33. Harlow E and Lane D (1999) Immunoaffinity purification. In Using Antibodies; A Laboratory Manual, 1st edn. (New York: Cold Spring Harbor Laboratory) pp. 311-343
34. Kaplan MH, Zong RT, Henscher RF, Scheuermann RH and Tucker PW (2001) Transcriptional activation by a matrix associating region-binding protein. Contextual requirements for the function of bright. J. Biol. Chem. 276: 21325-21330
35. Peeper DS, Shvarts A, Brummelkamp T, Douma S, Koh EY, Daley GQ and Bernards R (2002) A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence. Nat. Cell Biol. 4: 148-153
36. Smith P, Krohn R, Hermanson G, Mallia A, Gartner F, Provenzano M, Fujimoto E, Goeke N, Olson B and Klenk D (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85